IP Library Patent Application 13102956
Patent Application
App. No. 13/102,956

VASO-OCCLUSIVE DEVICES WITH ATTACHED POLYMER STRUCTURES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/102,956
Abstract

Disclosed herein are vaso-occlusive devices for forming occluding the vasculature of a patient. More particularly, disclosed herein are vaso-occlusive devices comprising at least one polymer structure and methods of making and using these devices.

Claims (21)

1 . A vaso-occlusive device comprising a core element having an outer surface and a polymer structure surrounding a substantial portion of the outer surface of the core element, wherein the polymer structure is a multi-layered polymeric structure, comprising an inner polymer member and an outer polymer member, wherein the outer polymer member covers the inner polymer member.

2 . The vaso-occlusive device of claim 1 , wherein the polymer structure is shaped into a tubular sheath.

3 . The vaso-occlusive device of claim 1 , wherein the inner polymer member comprises monofilaments or multi-filaments.

4 . The vaso-occlusive device of claim 3 , wherein the inner polymer member is wound into a helical shape.

5 . The device of claim 1 , wherein the outer polymer member comprises monofilaments or multi-filaments.

6 . The device of claim 5 , wherein the outer polymer member is braided into a tubular shape.

7 . The vaso-occlusive device of claim 1 , wherein the inner polymer member comprises a closed pitch coil and the outer polymer member comprises a braided tubular structure.

8 . The vaso-occlusive device of claim 1 , wherein the polymer structure comprises one or more biodegradable polymers.

9 . The vaso-occlusive device of claim 8 , wherein the biodegradable polymers comprises at least one polymer selected form group consisting of: lactide, glycolide, trimethylene carbonate and caprolactone polymers and their copolymers; hydroxybutyrate and polyhydroxyvalerate and their block and random copolymers; a polyether ester; anhydrides, polymers and copolymers of sebacic acid, hexadecandioic acid; and orthoesters.

10 . The vaso-occlusive device of claim 1 , where the polymer structure comprises one or more non-biodegradable polymers.

11 . The vaso-occlusive device of claim 10 , wherein the non-biodegradable polymers comprises at least one polymer selected from the group consisting of polyethylene teraphthalate, polytetraflouroethylene, polyurethane, polypropylene and Nylon materials.

12 . The vaso-occlusive device of claim 1 , where the polymer structure comprises one or more non-biodegradable polymers and one or more biodegradable polymers.

13 . The vaso-occlusive device of claim 1 , wherein the inner polymer member comprises a biodegradable polymer and the outer polymer member comprises a non-biodegradable polymer.

14 . The vaso-occlusive device of claim 1 , wherein the outer non-biodegradable polymer member comprises openings which allow the inner biodegradable polymer member to biodegrade through the openings.

15 . The vaso-occlusive device of claim 1 , wherein the core element comprises a wire formed into a helically wound primary shape.

16 . The vaso-occlusive device of claim 15 , where the core element has a secondary shape that self-forms upon deployment.

17 . The vaso-occlusive device of claim 16 , where the secondary shape is selected from the group consisting of cloverleaf shaped, helically-shaped, figure-8 shaped, flower-shaped, vortex-shaped, ovoid, randomly shaped, and substantially spherical.

18 . The vaso-occlusive device of claim 16 , wherein the secondary shape comprises a series of conjoined helical segments.

19 . The vaso-occlusive device of claim 18 , wherein at least two of the conjoined helical segments have differing diameters or differing orientation axes.

20 . The vaso-occlusive device of claim 1 , further comprising a detachment junction.

21 . A method of at least partially occluding an aneurysm, the method comprising introducing a vaso-occlusive device according to claim 1 into the aneurysm.

Assignments (6)
CHANGE OF NAME Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC
Reel/Frame 052860/0716 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052861/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT. Recorded Mar 8, 2016
From: STRYKER NV OPERATIONS LIMITED
To: STRYKER MEDTECH LIMITED
Reel/Frame 038039/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014. Recorded Mar 8, 2016
From: STRYKER MEDTECH LIMITED
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 038043/0011 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 23, 2015
From: STRYKER NV OPERATIONS LIMITED
To: STRYKER MEDTECH LIMITED
Reel/Frame 037153/0034 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 23, 2015
From: STRYKER MEDTECH LIMITED
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 037153/0241 →